Autoimmune Hepatitis Guide: Diagnosis, Steroids, and Azathioprine

Autoimmune Hepatitis Guide: Diagnosis, Steroids, and Azathioprine

Imagine waking up with profound fatigue and a yellow tint to your skin, only to find out your own immune system is attacking your liver. That is the reality of Autoimmune Hepatitis is a chronic inflammatory liver disease where the body's immune response mistakenly targets liver autoantigens, causing persistent inflammation. Also known as AIH, it is a serious condition that can lead to permanent scarring if left unchecked. While the diagnosis process can feel like a puzzle, understanding the pillars of treatment-specifically corticosteroids and azathioprine-is key to regaining control of your health.

For most people, the goal isn't just to "fix" a blood test result, but to stop the progression toward cirrhosis and liver failure. The good news is that with modern protocols, many patients achieve complete biochemical remission, meaning their liver enzymes return to normal and the inflammation stops.

How Doctors Diagnose AIH

There is no single "magic test" for AIH. Instead, doctors use a combination of blood work, imaging, and tissue samples to build a case. If you are suspected of having AIH, your medical team will look for a specific set of markers.

First, they check your Immunoglobulin G (IgG) levels. In most AIH patients, these levels are at least 1.5 times higher than normal. They also look for autoantibodies. While older guidelines split these into Type 1 and Type 2, the European Association for the Study of the Liver (EASL) recently updated their 2025 guidelines to move away from these subclasses because they don't actually change how the disease is treated.

The gold standard for confirmation is a liver biopsy. A thin needle is used to take a small sample of liver tissue. Pathologists look for "interface hepatitis," which is inflammation concentrated where the portal tracts meet the liver cells. To be accurate, they typically examine at least 20 portal tracts per specimen.

To make things objective, clinicians often use the Revised International Autoimmune Hepatitis Group (IAIHG) scoring system. This assigns points based on your symptoms, antibodies, and biopsy results. A score over 20 usually confirms a definite diagnosis of AIH.

The Role of Steroids in Initial Treatment

When you first start treatment, the priority is to put out the "fire" of inflammation quickly. This is where Prednisone is a potent corticosteroid used to rapidly suppress the immune system and reduce liver inflammation comes in. Most patients start with a dose of 0.5 to 1 mg per kilogram of body weight daily.

The response to steroids is often remarkably fast. About 80-90% of patients see their liver enzymes drop within just two weeks. However, steroids are a double-edged sword. While they save the liver, long-term use can lead to significant side effects. You might experience "moon face" (swelling of the face), rapid weight gain, insomnia, and an increased risk of developing type 2 diabetes or osteoporosis.

Because of these risks, the goal is always to taper the prednisone dose down-usually to around 10-15 mg per day-as soon as a second medication can take over the heavy lifting.

Simplified scale balancing two different types of medication pills.

Using Azathioprine for Long-Term Stability

To reduce the reliance on steroids, doctors introduce Azathioprine is an immunosuppressant medication that helps maintain remission and allows for the reduction of corticosteroid doses . Often sold under brands like Imuran or Azasan, this drug acts as a "steroid-sparing" agent.

By combining azathioprine with a lower dose of prednisone, patients can often reduce their steroid intake by 70-80% within six months. This drastically cuts down the risk of steroid-induced cataracts or mood swings. The typical target dose is 1-2 mg per kg of body weight.

However, azathioprine isn't for everyone. A small percentage of people have a genetic deficiency in an enzyme called TPMT. If you lack this enzyme, azathioprine can cause severe bone marrow suppression, which is dangerous. Because of this, the 2025 EASL guidelines strongly recommend TPMT enzyme testing before the first dose is ever given.

Comparison of First-Line AIH Treatments
Feature Prednisone (Steroids) Azathioprine
Primary Goal Rapidly reduce inflammation Long-term maintenance & steroid sparing
Speed of Action Very Fast (days/weeks) Slow (months)
Common Side Effects Weight gain, insomnia, diabetes Nausea, fatigue, bone marrow issues
Required Screening Blood glucose/pressure TPMT Enzyme Testing

Managing the Treatment Journey

Living with AIH is a marathon, not a sprint. Monitoring is constant. In the beginning, you'll likely have blood tests for ALT and AST every 2 to 4 weeks. Once you hit the maintenance phase, this usually drops to every three months.

One critical step before starting any immunosuppressant is screening for Hepatitis B. This is because drugs like azathioprine can cause a dormant Hepatitis B infection to reactivate, which could lead to sudden liver failure. Doctors will check for HBsAg and anti-HBc antibodies to ensure you are safe to proceed.

After 18 to 24 months of therapy, many doctors suggest a second biopsy. Why? Because blood tests can sometimes look "normal" even if the liver is still slightly inflamed. A biopsy confirms "histological remission," meaning the tissue itself has actually healed. About 50-70% of patients achieve this level of recovery after a few years of treatment.

A winding path with medical symbols leading toward a bright sun symbolizing recovery.

What Happens if First-Line Therapy Fails?

Unfortunately, about 10-15% of people don't respond well to the prednisone/azathioprine combo. Some might develop pancreatitis or find the side effects unbearable. In these cases, doctors pivot to second-line therapies.

Mycophenolate Mofetil is a second-line immunosuppressant used when patients cannot tolerate or do not respond to azathioprine is a common alternative. It is often more effective for those who failed the first line of defense. More recently, research into JAK inhibitors and monoclonal antibodies is showing promise for refractory cases, though these are not yet standard for everyone.

The question of whether to stop medication entirely is a point of debate. While some patients try to taper off after years of remission, the relapse rate is staggeringly high-between 50% and 90%. Most experts suggest a very slow withdrawal over 6 to 12 months with incredibly close monitoring.

How long do I have to take AIH medication?

For the majority of patients (60-80%), treatment is long-term or even lifelong. Because the relapse rate is so high when medication is stopped, many stay on a low maintenance dose of azathioprine and a tiny amount of prednisone to keep the disease in check.

Is a liver biopsy always necessary?

Yes, according to the 2025 EASL guidelines, a biopsy remains mandatory for the initial diagnosis. It is the only way to confirm interface hepatitis and rule out other causes of liver damage that might look like AIH on a blood test.

What is the risk of the biopsy procedure?

The risk of major complications, such as severe bleeding, is very low-estimated between 0.1% and 0.3%. Most biopsies are performed under ultrasound guidance to maximize safety.

Can AIH cause permanent liver damage?

If left untreated, AIH can lead to cirrhosis and liver failure. However, if caught early and treated correctly, treatment can actually reverse some of the fibrosis (scarring), moving a patient from a more advanced stage (like F3) back to a healthier state (F0).

Why do I need a TPMT test before starting Azathioprine?

The TPMT test identifies if you have a genetic deficiency in the enzyme that breaks down azathioprine. People with this deficiency have a 30-fold higher risk of severe bone marrow suppression, which can be life-threatening if the dose isn't adjusted.

Next Steps and Support

If you have just been diagnosed, your first priority should be establishing a relationship with a hepatologist. Ensure you have a clear schedule for your blood tests and a plan for tapering your steroids to avoid the most severe side effects.

For those struggling with the emotional toll of "prednisone mood swings" or the physical changes of steroid use, joining a patient advocacy group can be a lifeline. Knowing that the "moon face" or insomnia is a temporary part of the initial phase makes the process much easier to handle.

If you find that your current medication isn't working after 12-18 months, don't panic. This is a known occurrence in about 10-15% of cases, and moving to a second-line therapy like mycophenolate mofetil often solves the problem and stabilizes liver function.